Insider Transactions in Q4 2025 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
John Patrick Shannon Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,100
+3.09%
|
$87,100
$1.55 P/Share
|
|
Nov 13
2025
|
John Patrick Shannon Jr Director |
SELL
Open market or private sale
|
Direct |
23,242
-0.87%
|
$162,694
$7.46 P/Share
|
|
Nov 13
2025
|
John Patrick Shannon Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,970
+0.34%
|
$8,970
$1.55 P/Share
|
|
Nov 11
2025
|
Beth Hecht Officer |
SELL
Open market or private sale
|
Direct |
16,667
-1.23%
|
$116,669
$7.4 P/Share
|
|
Oct 02
2025
|
Kevin Mc Culloch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-0.04%
|
$5,864
$8.31 P/Share
|